移码TSH受体变异Val711Phefs*18因获得疏水性降解子而失活
该研究在一例先天性甲状腺功能减退症患者中鉴定出位于TSHR胞内C尾的移码变异p.Val711Phefs*18,体外证实其功能丧失且蛋白表达降低;移码序列融合至绿色荧光蛋白或荧光素酶可诱导其失活,提示该序列作为降解子,且疏水残基密度决定稳定性。
要点
- TSHR胞内C尾移码变异p.Val711Phefs*18导致功能丧失。
- 移码序列作为降解子,其疏水残基密度决定蛋白稳定性。
- 另一移码变异Thr748Profs*27具有类似效应。
核心结论
- 位于TSHR胞内C尾的移码变异p.Val711Phefs*18通过获得疏水性降解子导致受体失活。
研究设计与样本
- 对一例先天性甲状腺功能减退症患者进行TSHR测序,并在HEK293细胞中表达TSHR,检测TSH依赖的cAMP反应元件-荧光素酶报告基因活性。
- 进行系统性突变实验以表征移码氨基酸序列,并构建覆盖C尾所有可能移码框的8个额外移码TSHR变异。
主要发现
- 先证者携带已知TSHR变异p.Arg519His和新型移码变异p.Val711Phefs*18的杂合状态。
- p.Val711Phefs*18-TSHR体外功能丧失,而p.Val711*-TSHR功能正常。
- Western blotting显示p.Val711Phefs*18-TSHR蛋白表达低。
- 移码序列融合至绿色荧光蛋白或荧光素酶可诱导其失活,提示该序列作为降解子。
- 系统性突变研究揭示移码序列中疏水残基的密度决定稳定性。
临床怎么用
- 对于先天性甲状腺功能减退症患者,若发现TSHR胞内C尾移码变异,应评估其通过疏水性降解子导致受体失活的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Inactivating variants of thyrotropin (thyroid-stimulating hormone; TSH) receptor (TSHR) cause congenital hypothyroidism. More than 60 such variants have been reported so far, most of which were located in the extracellular or transmembrane domain. OBJECTIVE: We report the identification and characterization of a frameshift TSHR variant in the intracytoplasmic C-tail region. METHODS: Sequencing of TSHR was performed in a patient with congenital hypothyroidism. The functionality of the identified variants was assessed by expressing TSHR in HEK293 cells and measuring TSH-dependent activation of the cAMP-response element-luciferase reporter. A series of systematic mutagenesis experiments were performed to characterize the frameshifted amino acid sequence. RESULTS: The proband was heterozygous for a known TSHR variant (p.Arg519His) and a novel frameshift TSHR variant (p.Val711Phefs*18), which removed 54 C-terminal residues and added a 17-amino acid frameshifted sequence. The loss of function of Val711Phefs*18-TSHR was confirmed in vitro, but the function of Val711*-TSHR was found to be normal. Western blotting showed the low protein expression of Val711Phefs*18-TSHR. Fusion of the frameshift sequence to green fluorescent protein or luciferase induced inactivation of them, indicating that the sequence acted as a degron. A systematic mutagenesis study revealed that the density of hydrophobic residues in the frameshift sequence determined the stability. Eight additional frameshift TSHR variants that covered all possible shifted frames in C-tail were created, and another frameshift variant (Thr748Profs*27) with similar effect was found. CONCLUSIONS: We characterized a naturally occurring frameshift TSHR variant located in C-tail, and provided a unique evidence that hydrophobicity in the C-terminal region of the receptor affects protein stability.
引用
- Sugisawa C, Ono M, Kashimada K, et al. Inactivation of a Frameshift TSH Receptor Variant Val711Phefs*18 is Due to Acquisition of a Hydrophobic Degron. J Clin Endocrinol Metab. 2021. PMID: 33108452. doi:10.1210/clinem/dgaa772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。